Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine
Authors
Keywords
-
Journal
Acupuncture in Medicine
Volume 34, Issue 6, Pages 463-470
Publisher
BMJ
Online
2016-11-14
DOI
10.1136/acupmed-2016-011113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation
- (2015) K Hoehlig et al. BRITISH JOURNAL OF PHARMACOLOGY
- Calcitonin gene-related peptide and migraine
- (2015) Nazia Karsan et al. CURRENT OPINION IN NEUROLOGY
- Acupuncture for Migraine Prevention
- (2015) Arnaldo Neves Da Silva HEADACHE
- Acupuncture decreases matrix metalloproteinase-2 activity in patients with migraine
- (2014) Yasemin Cayir et al. Acupuncture in Medicine
- Association of pre- and post-treatment expectations with improvements after acupuncture in patients with migraine
- (2014) Hui Zheng et al. Acupuncture in Medicine
- CGRP and migraine: Could PACAP play a role too?
- (2013) Eric A. Kaiser et al. NEUROPEPTIDES
- Evaluating the prophylaxis and long-term effectiveness of acupuncture for migraine without aura: study protocol for a randomized controlled trial
- (2013) Jiao Chen et al. Trials
- A sham-controlled trial of acupuncture as an adjunct in migraine prophylaxis
- (2013) Mohsen Foroughipour et al. Acupuncture in Medicine
- CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint
- (2012) Delane Viana Gondim et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies
- (2012) Kathryn A. Seely et al. NEUROPHARMACOLOGY
- Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system
- (2012) Jan Hoffmann et al. PAIN
- Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin
- (2011) Matthias A. Engel et al. NEUROPEPTIDES
- Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial
- (2011) Lin-Peng Wang et al. PAIN
- IL-1β Stimulates COX-2 Dependent PGE2 Synthesis and CGRP Release in Rat Trigeminal Ganglia Cells
- (2011) Lars Neeb et al. PLoS One
- Electroacupuncture enhances cell proliferation and neuronal differentiation in young rat brains
- (2010) Jianfeng Gao et al. NEUROLOGICAL SCIENCES
- A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain
- (2010) Xiao Hong Yu et al. PAIN
- The relevance of preclinical research models for the development of antimigraine drugs: Focus on 5-HT1B/1D and CGRP receptors
- (2010) Saurabh Gupta et al. PHARMACOLOGY & THERAPEUTICS
- Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions
- (2009) T M Fong et al. INTERNATIONAL JOURNAL OF OBESITY
- Variations in the cannabinoid receptor 1 gene predispose to migraine
- (2009) Gabriella Juhasz et al. NEUROSCIENCE LETTERS
- Pretreatment With Electroacupuncture Induces Rapid Tolerance to Focal Cerebral Ischemia Through Regulation of Endocannabinoid System
- (2009) Qiang Wang et al. STROKE
- Epidemiology and comorbidity of headache
- (2008) Rigmor Jensen et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started